Cerulean-N1 Citations (11)
Originally described in: An improved cyan fluorescent protein variant useful for FRET.Rizzo MA, Springer GH, Granada B, Piston DW Nat Biotechnol. 2004 Apr . 22(4):445-9. PubMed Journal
Articles Citing Cerulean-N1
| Articles |
|---|
| A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining. Moureau S, Luessing J, Harte EC, Voisin M, Lowndes NF. Open Biol. 2016 Sep;6(9). pii: 160225. PubMed |
| Mimicking transient activation of protein kinases in living cells. Klomp JE, Huyot V, Ray AM, Collins KB, Malik AB, Karginov AV. Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):14976-14981. doi: 10.1073/pnas.1609675114. Epub 2016 Dec 12. PubMed |
| A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking. Khare S, Nick JA, Zhang Y, Galeano K, Butler B, Khoshbouei H, Rayaprolu S, Hathorn T, Ranum LPW, Smithson L, Golde TE, Paucar M, Morse R, Raff M, Simon J, Nordenskjold M, Wirdefeldt K, Rincon-Limas DE, Lewis J, Kaczmarek LK, Fernandez-Funez P, Nick HS, Waters MF. PLoS One. 2017 May 3;12(5):e0173565. doi: 10.1371/journal.pone.0173565. eCollection 2017. PubMed |
| Non-canonical regulation of homologous recombination DNA repair by the USP9X deubiquitylase. O'Dea R, Santocanale C. J Cell Sci. 2020 Feb 12;133(3):jcs233437. doi: 10.1242/jcs.233437. PubMed |
| Concentration-dependent splicing is enabled by Rbfox motifs of intermediate affinity. Begg BE, Jens M, Wang PY, Minor CM, Burge CB. Nat Struct Mol Biol. 2020 Oct;27(10):901-912. doi: 10.1038/s41594-020-0475-8. Epub 2020 Aug 17. PubMed |
| CaMKII oxidation is a critical performance/disease trade-off acquired at the dawn of vertebrate evolution. Wang Q, Hernandez-Ochoa EO, Viswanathan MC, Blum ID, Do DC, Granger JM, Murphy KR, Wei AC, Aja S, Liu N, Antonescu CM, Florea LD, Talbot CC Jr, Mohr D, Wagner KR, Regot S, Lovering RM, Gao P, Bianchet MA, Wu MN, Cammarato A, Schneider MF, Bever GS, Anderson ME. Nat Commun. 2021 May 26;12(1):3175. doi: 10.1038/s41467-021-23549-3. PubMed |
| Characterization of the Striatal Extracellular Matrix in a Mouse Model of Parkinson's Disease. Freitas A, Aroso M, Barros A, Fernandez M, Conde-Sousa E, Leite M, Carvalho ED, Ribeiro CC, Ferreira R, Pego AP, Vitorino R, Gomez-Lazaro M. Antioxidants (Basel). 2021 Jul 8;10(7). pii: antiox10071095. doi: 10.3390/antiox10071095. PubMed |
| Lack of CD8(+) T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer. Horton BL, Morgan DM, Momin N, Zagorulya M, Torres-Mejia E, Bhandarkar V, Wittrup KD, Love JC, Spranger S. Sci Immunol. 2021 Oct 29;6(64):eabi8800. doi: 10.1126/sciimmunol.abi8800. Epub 2021 Oct 29. PubMed |
| Type I interferon activates MHC class I-dressed CD11b(+) conventional dendritic cells to promote protective anti-tumor CD8(+) T cell immunity. Duong E, Fessenden TB, Lutz E, Dinter T, Yim L, Blatt S, Bhutkar A, Wittrup KD, Spranger S. Immunity. 2022 Feb 8;55(2):308-323.e9. doi: 10.1016/j.immuni.2021.10.020. Epub 2021 Nov 19. PubMed |
| Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53. Strachotova D, Holoubek A, Wolfova K, Brodska B, Herman P. FEBS J. 2023 Apr 29. doi: 10.1111/febs.16810. PubMed |
| The p24-family and COPII subunit SEC24C facilitate the clearance of alpha1-antitrypsin Z from the endoplasmic reticulum to lysosomes. Roberts BS, Mitra D, Abishek S, Beher R, Satpute-Krishnan P. Mol Biol Cell. 2024 Mar 1;35(3):ar45. doi: 10.1091/mbc.E23-06-0257. Epub 2024 Jan 31. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.